Prevalence of central sensitisation associated symptoms and associations with treatment outcomes in surgical, interventional and injection-based treatment for patients with chronic spinal pain.

ABSTRACT:

Objectives

This study aimed to assess the prevalence of symptoms potentially related to central sensitisation (CS) in patients with spinal pain and explore its association with patient-reported treatment outcomes.

Methods

This study was designed as a single-centre prospective cohort study evaluating 496 patients undergoing surgical and non-surgical management for spinal pain between 2020 and 2023. Patients with symptoms lasting more than three months were assessed for symptoms associated with CS using the validated Central Sensitisation Inventory (CSI) before treatment. Treatment satisfaction was then assessed using a 5-point Likert scale. Complete data on patient demographics were available for 492 patients.

Results

The prevalence of a CSI score of 40+ was 49.9%. Non

SUBMITTER: Zotti MG 

PROVIDER: S-EPMC12547141 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature